An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation

American Journal of Gastroenterology

Volumn 95, Issue 12, 2000, Pages 3579-3583

  Ben Ari, Z ^a   Broida, E ^b   Kittai, Y ^b   Chagnac, A ^b   Tur Kaspa, R ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; PREDNISOLONE; STEROID; TACROLIMUS; VIRUS DNA;

ABDOMINAL PAIN; ADULT; ARTICLE; CHRONIC HEPATITIS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; NAUSEA; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS HEPATITIS; VIRUS REPLICATION;

ADULT; HEPATITIS B, CHRONIC; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LAMIVUDINE; MALE; MIDDLE AGED; PILOT PROJECTS; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS REPLICATION;

EID: 0033634833     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02089-X     Document Type: Article

References (22)

1. Hepatitis B liver disease in cyclosporine-treated renal allograft recipients
2. Renal transplantation in asymptomatic carriers of hepatitis B surface antigen
3. Prevalence and clinical course of hepatitis B and hepatitis C liver disease in cyclosporine-treated renal allograft recipients
4. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection
5. The impact of renal transplantation on the course of hepatitis B liver disease
6. Renal transplantation is not contraindicated in asymptomatic carriers of hepatitis B surface antigen
7. Chronic hepatitis in kidney allograft recipients
8. The increased risk of fatal liver disease in renal transplant patients who are hepatitis Be antigen and/or HBV DNA positive
9. Hepatitis B virus, and hepatitis-B-related viral infection in renal transplant recipients
10. Membranous nephropathy related to hepatitis B virus in adults
11. Interferon-alpha facilitates renal transplantation in hemodialysis patients with chronic viral hepatitis
12. A preliminary trial of lamivudine for chronic hepatitis B infection
13. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation
14. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation
15. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
16. Transection of oesophagus for bleeding oesophagus varices
17. Hepatitis B vires precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity
18. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients
19. Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation
20. Hepatitis-B-vires resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
21. High pre-treatment serum hepatitis B virus fitre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation
22. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation